EDT.TO/ Spectral medical

Search

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
Intersting..This gives them standardize regulatory requirements that only needs to be audited once for 5 markets…Australia, Brazil, Canada Japan and the US…Spectral's market is only North America …Maybe this was the way to get both the US and Canada in one shot…although I do know talk has been about expanding the market with the partner in Europe...


This should make them a little more attractive as a M&A move.


fed0372a-a1bf-4e28-ad49-8534c1204b3c.jpg
Spectral Medical Announces that its wholly owned subsidiary Dialco Medical has received MDSAP certification
  • MDSAP is the highest quality and regulatory standard in the medical device industry

TORONTO, Canada – November 24, 2020 – Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market, today announced that its wholly owned subsidiary, Dialco Medical Inc. (“Dialco”) received its Medical Device Single Audit Program (“MDSAP”) certification for “the design, manufacture, installation and service of equipment for extracorporeal blood purification and its related disposable” under ISO 13485 for Canada (Medical Devices Regulations – Part 1- SOR 98/282) and United States (21 CFR 820, 21 CFR 803, 21 CFR 806, 21 CFR 807 (Subparts A to D), 21 CFR 821).

MDSAP allows the conduct of a single regulatory audit of a medical device manufacturer's quality management system to satisfy the requirements of multiple regulatory jurisdictions or authorities to enable appropriate regulatory oversight of medical device manufacturers’ quality management systems while minimizing regulatory burden on the industry. The program was developed by the International Medical Device Regulators Forum and currently representatives from The Therapeutic Goods Administration in Australia; Brazil’s Agência Nacional de Vigilância Sanitária; Health Canada Canadian Medical Device Regulations; Japan’s Ministry of Health, Labour and Welfare and Pharmaceutical and Medical Devices Agency, and the U.S. Food and Drug Administration, Center for Devices and Radiological Health participate in the program.

“On Dialco’s continued commercialization path, MDSAP and ISO 13485 certifications represent important milestones. Not only does certification through these programs validate our ongoing commitment to maintaining the highest quality assurance standards within the medical device industry, but MDSAP certification is also a Health Canada mandated requirement to sell medical devices in Canada,” said Dr. Gualtiero Guadagni, President of Dialco. “Additionally, Dialco’s receipt of its own MDSAP certification supports Dialco’s continuous pathway of achieving a fully independent operating structure."

About Spectral and Dialco

Spectral is a Phase III company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin™ (“PMX”). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s Endotoxin Activity Assay (EAA™), the only FDA cleared diagnostic for the risk of developing sepsis.

PMX is approved for therapeutic use in Japan and Europe, and has been used safely and effectively on more than 200,000 patients to date. In March 2009, Spectral obtained the exclusive development and commercial rights in the U.S. for PMX, and in November 2010, signed an exclusive distribution agreement for this product in Canada. Approximately 330,000 patients are diagnosed with severe sepsis and septic shock in North America each year.

Spectral, through its wholly owned subsidiary, Dialco Medical Inc. (“Dialco”), is also commercializing a new proprietary platform, “SAMI”, targeting the renal replacement therapy (“RRT”) market. Dialco is also seeking regulatory approval for in-home use of “DIMI” which is based on the same RRT platform, but will be intended for home hemodialysis use. “DIMI” recently received its FDA 510k clearance for use in hospital and clinical settings.

Spectral is listed on the Toronto Stock Exchange under the symbol EDT. For more information, please visit www.spectraldx.com.

Forward-looking statement

Information in this news release that is not current or historical factual information may constitute forward-looking information or forward looking statements within the meaning of securities laws. Implicit in this information, particularly in respect of the future outlook of Spectral and anticipated events or results, are assumptions based on beliefs of Spectral's senior management as well as information currently available to it. While these assumptions were considered reasonable by Spectral at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results are subject to a number of risks and uncertainties, including the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of Spectral to take advantage of business opportunities in the biomedical industry, the granting of necessary approvals by regulatory authorities including but not limited to the ongoing impact of COVID-19. Actual results could differ materially from what is currently expected, and readers are cautioned not to place undue reliance on these forward-looking statements. Except as required by law, the Company disclaims any obligation to update or revise any forward-looking statements. Reference is also made to the other risks and uncertainties that may affect the Company which are more fully described in Spectral’s Annual Information Form dated March 26, 2020 and other filings of Spectral with the securities regulatory authorities which are available at www.sedar.com.

 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
One note...

Dec 4th the company is having an online investors day...It's a bit of a head scratcher unless they have real market worthy news, Like a move up in markets or some sort of approval...It better be something to draw attention when this company has done nothing but hide over the past years.

PR isn't these guys game at all..Hopefully it's a strong presentation otherwise..Ufffff
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
Paradigm with a 4 dollar buy placed on EDT yesterday..
Looking for the release...

`
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
I've been wondering what the direction here will be...They'll need to split the pump off the filter part of the company, then finance the new pump company with a small IPO?
It's looking like something has to happen hear to separate the values...I like it the idea..some won't but with the FDA involved two shots on goal are always better than one.
One being the filter the other being the pump..How share holders are going to be represented in a new company would be my main question...If it's a question all.
They asked for more info than I wanted to give to get into the call but I then remembered they know where every share is placed...I've written Spinnaker many times and my share count was noted by the company rep @ spinnaker..witch I found amazing.






TORONTO, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) , a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly owned subsidiary Dialco Medical Inc. ( “ Dialco ” ), today announced the details for the Company’s upcoming Virtual Investor Day, scheduled to be held on Friday, December 4, 2020 at 10:00 a.m. EST.

Members of Spectral’s leadership team will provide a detailed status update on the progress of the Tigris trial as well as the approvals and advancements towards commercialization at Dialco. In addition, the Company will provide commentary on its balance sheet and the capital markets environment.
To preregister for the webcast presentation, please visit Spectral Medical Inc. Virtual Investor Day
The event will include a question and answer session. In the interest of time, investors are encouraged to submit their questions in advance via email to fb@spinnakercmi.com . Management will also address questions live during the webcast.
For anyone who is unable to participate on the day of the event, the webcast will be available to view online until 11:59 p.m. EST, Tuesday, January 5, 2021.
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
Waiting here for a bit but a report came out with a 4 dollar target on EDT.
Up 6% today not that it means much in the big picture ..the volume isn't great but there is a mysterious house in Asia buying lately but in a very clear mathematical way...M&A heating up here in the background.
Next year I'm hoping this gets resolved either way..I don't mind holding equities if I believe ...this hold has been my longest speculative hold of my life by a long shot.
I do think they have a very good chance here still for a 10 bagger eventually...it's a big bet , I've added a small amount recently.

If you have question PM me..I get nervous putting much out about this stock...
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
Yep nice little move CB

People are speculating this is being driven to the 60 cent range for a financing....Makes some sense actually as the last round was done at the .61 level, funding or splitting the pump off as another Co. is a real possibility IMO....
If it keeps moving Monday I'll be a buyer for a short hold of some amount till around the 60 cent area then sell the part I bought and continue the long hold on the remaining position.
60 cents would be around a 30% premium as it stands today...Worth watching next week.

Done for the day..enjoy your Sunday fellas
 

Member
Joined
Apr 30, 2009
Messages
5,008
Tokens
Lobbyists everywhere I guess.
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
I bought this AM..I'm watching the alternate symbols mostly... Pools of money are hitting the less apparent markets and the houses buying are outa Asia.
Fridays volume on the surface looked like 120k between the US and Canada...If you'd checked the alternative markets on Friday it traded 320K witch is unusual.

Pretty interesting.




T:EDT - SPECTRAL MEDICAL INC - http://www.spectraldx.com11:03:08 EST
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
EDT - T ▲ATS10.50.425·0.430.50.4375.632350.435 0.44 0.430.85 0.34510:42:01Nov 2715 min RT 2¢
TSX - T10.50.425·0.430.50.4314.46210.435 0.44 0.430.85 0.34510:42:0115 min
NEO ATS - U 0.435+0.0051.222.0930.43 0.435 0.4310:08:5615 min
Alpha - A 0.44+0.012.319.2830.44 0.44 0.4409:45:4415 min
Omega - O 0.4317.5820.43 0.43 0.4309:35:3915 min
CX2 - H 0.432.0120.43 0.43 0.4309:30:4015 min
TriAct - M 0.430.504 Sep 11 14:53:4615 min


 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
Interesting Pressure on the bid this AM...Not that it means anything but it should bump up today
 

Member
Joined
Oct 9, 2006
Messages
1,930
Tokens
Looks like we finallly signed a U.S I/R firm.

Crescendo Communications, LLC
https://www.crescendo-ir.com/clients

Some very notable biotech clients, including IPA.V.

If we can get someone to effectively share our story and execute an uplisting to the NASDAQ (like IPA has over recent months), we can see big moves.
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
Looks like we finallly signed a U.S I/R firm.

Crescendo Communications, LLC
https://www.crescendo-ir.com/clients

Some very notable biotech clients, including IPA.V.

If we can get someone to effectively share our story and execute an uplisting to the NASDAQ (like IPA has over recent months), we can see big moves.

Yeah..it's looking good Steiner..all the parts are finally aligning...Someone will buy them, I still think Baxter wants both the filter and the machine..Time is ticking and the longer this runs down the FDA lines the more the buy out price will increase.
I like it and might just step to buy another small part.


You've had guts sticking with this and now with a PR firm it might be a bit easier information wise.
 

Member
Joined
Dec 13, 2007
Messages
13,673
Tokens
Year high is 42 cents US..it's nothing but is around a 20% premium from todays price...of 34 cents
I think this pushes the year high shortly...if not you've got something promising in the medium run.


I bought a tad today.
 

Forum statistics

Threads
1,120,309
Messages
13,580,082
Members
100,959
Latest member
undrstand03
The RX is the sports betting industry's leading information portal for bonuses, picks, and sportsbook reviews. Find the best deals offered by a sportsbook in your state and browse our free picks section.FacebookTwitterInstagramContact Usforum@therx.com